+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Virtual and Augmented Reality in Healthcare Market By Component: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994267
The virtual and augmented reality in healthcare market was valued at $2.5 billion in 2023, and is projected to reach $14.9 billion by 2033, growing at a CAGR of 19.6% from 2024 to 2033.

Augmented reality (AR) and virtual reality (VR) serve as practical tools in modern medical practices. AR facilitates the accumulation of data, which is subsequently represented as 3D model, whereas VR is used for recreation of the environment virtually. These technologies are revolutionizing the processes such as surgical simulations, patient care, remote consultation, and medical training.

The growth of the virtual and augmented reality in healthcare market is majorly driven by increase in demand for AR and VR in healthcare to improve imaging methods, patient treatment programs, and surgical training. In addition, alarming increase in the prevalence of chronic diseases necessitates innovative treatment and management solutions, which VR and AR can provide through remote monitoring, rehabilitation, and patient education, thereby contributing toward the growth of the market. Moreover, surge in demand for better training tools drives the adoption of VR and AR for realistic simulations, allowing medical students and professionals to practice procedures in a safe, controlled environment. The planning and performance of intricate surgical procedures, as well as the training of medical professionals, are greatly improved by immersive and interactive settings of these technologies. Surgeons may practice procedures in 3D settings created by VR that are realistic and immersive, all without putting patients at danger. Surgeons can improve their skills and decision-making processes by using these simulators, which can recreate a variety of circumstances, including uncommon and challenging instances. For instance, in 2022, with the assistance of VR-enabled surgical procedure, a pair of conjoined twins, Bernardo and Arthur Lima - three-year-olds from Brazil - were successfully separated. As these twins were born joint at the head with their brains interconnected, medical experts were of the opinion that it was impossible to separate them and ensure there was no loss of life. However, the surgery was accomplished successfully with the help of VR technology in a hospital in Rio de Janeiro that was directed live by Dr. Noor ul Owase Jeelani from a hospital in London. This extraordinary surgical intervention stands as a benchmark in enhancing surgical precision and patient outcomes. However, high expense of the gadget and the requirement for a lot of processing power limit the adoption of AR and VR. Moreover, concerns associated with user satisfaction and safety significantly hamper the market growth. Around 65% of the respondents have experienced concerns about comfort, usability, and the immersive nature of AR and VR devices, indicating these as the most common barriers faced among users. Thus, improving the practicality and usability of these technologies is essential for their wider acceptance. In addition, about 27% of the respondents mentioned about the cost to consumers. On the contrary, rise in investments from venture capitalists, government grants, and private sectors in VR and AR healthcare start-ups and research initiatives is expected to offer remunerative opportunities for the expansion of the market during the forecast period. Moreover, continuous improvements in VR and AR hardware and software, such as better graphics, more powerful processors, and advanced sensors, will make these technologies more effective and accessible, thus opening new avenues for the expansion of the global market.

The VR and AR in healthcare industry is segmented into component, technology, end user, and region. By component, the market is divided into hardware, software, and services. On the basis of technology, it is categorized into augmented reality and virtual reality. Depending on end user, it is classified into hospitals, research institutions, diagnostic centers, and clinics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By component, the hardware segment dominated the market share in 2023.

On the basis of technology, the augmented reality segment was the major shareholder in 2023.

Depending on end user, the hospitals segment acquired the largest market share in 2023.

Region wise, North America held a dominant position in the market in 2023; however, Asia-Pacific is expected to register the highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global Virtual and Augmented Reality in Healthcare Market include CAE, GE Healthcare, Koninklijke Philips N.V., Intuitive Surgical, Inc., Siemens Ltd., Eon Reality, Inc, Bioflight VR, WorldViz, TheraSim Inc, and MindMaze. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold and sustain the intense competition.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Component

  • Hardware
  • Software
  • Services

By Technology

  • Augmented Reality
  • Virtual Reality

By End User

  • Hospitals
  • Research Institutions
  • Diagnostic Centers
  • Clinics

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • CAE
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Intuitive Surgical, Inc.
  • Siemens Ltd
  • Eon Reality, Inc
  • Bioflight VR
  • WorldViz
  • TheraSim Inc
  • MindMaze

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Component
4.2. Hardware
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Software
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Services
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Augmented Reality
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Virtual Reality
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Research Institutions
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Diagnostic Centers
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Clinics
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Component
7.2.3. Market Size and Forecast, By Technology
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Virtual and Augmented Reality in Healthcare Market
7.2.6.1. Market Size and Forecast, By Component
7.2.6.2. Market Size and Forecast, By Technology
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Virtual and Augmented Reality in Healthcare Market
7.2.7.1. Market Size and Forecast, By Component
7.2.7.2. Market Size and Forecast, By Technology
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Virtual and Augmented Reality in Healthcare Market
7.2.8.1. Market Size and Forecast, By Component
7.2.8.2. Market Size and Forecast, By Technology
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Component
7.3.3. Market Size and Forecast, By Technology
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Virtual and Augmented Reality in Healthcare Market
7.3.6.1. Market Size and Forecast, By Component
7.3.6.2. Market Size and Forecast, By Technology
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Virtual and Augmented Reality in Healthcare Market
7.3.7.1. Market Size and Forecast, By Component
7.3.7.2. Market Size and Forecast, By Technology
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Virtual and Augmented Reality in Healthcare Market
7.3.8.1. Market Size and Forecast, By Component
7.3.8.2. Market Size and Forecast, By Technology
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Virtual and Augmented Reality in Healthcare Market
7.3.9.1. Market Size and Forecast, By Component
7.3.9.2. Market Size and Forecast, By Technology
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Virtual and Augmented Reality in Healthcare Market
7.3.10.1. Market Size and Forecast, By Component
7.3.10.2. Market Size and Forecast, By Technology
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Virtual and Augmented Reality in Healthcare Market
7.3.11.1. Market Size and Forecast, By Component
7.3.11.2. Market Size and Forecast, By Technology
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Component
7.4.3. Market Size and Forecast, By Technology
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Virtual and Augmented Reality in Healthcare Market
7.4.6.1. Market Size and Forecast, By Component
7.4.6.2. Market Size and Forecast, By Technology
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Virtual and Augmented Reality in Healthcare Market
7.4.7.1. Market Size and Forecast, By Component
7.4.7.2. Market Size and Forecast, By Technology
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Virtual and Augmented Reality in Healthcare Market
7.4.8.1. Market Size and Forecast, By Component
7.4.8.2. Market Size and Forecast, By Technology
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Virtual and Augmented Reality in Healthcare Market
7.4.9.1. Market Size and Forecast, By Component
7.4.9.2. Market Size and Forecast, By Technology
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Virtual and Augmented Reality in Healthcare Market
7.4.10.1. Market Size and Forecast, By Component
7.4.10.2. Market Size and Forecast, By Technology
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Virtual and Augmented Reality in Healthcare Market
7.4.11.1. Market Size and Forecast, By Component
7.4.11.2. Market Size and Forecast, By Technology
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Component
7.5.3. Market Size and Forecast, By Technology
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Virtual and Augmented Reality in Healthcare Market
7.5.6.1. Market Size and Forecast, By Component
7.5.6.2. Market Size and Forecast, By Technology
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Virtual and Augmented Reality in Healthcare Market
7.5.7.1. Market Size and Forecast, By Component
7.5.7.2. Market Size and Forecast, By Technology
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Virtual and Augmented Reality in Healthcare Market
7.5.8.1. Market Size and Forecast, By Component
7.5.8.2. Market Size and Forecast, By Technology
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Virtual and Augmented Reality in Healthcare Market
7.5.9.1. Market Size and Forecast, By Component
7.5.9.2. Market Size and Forecast, By Technology
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. CAE
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. GE Healthcare
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Koninklijke Philips N.V.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Intuitive Surgical, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Siemens Ltd
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Eon Reality, Inc
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Bioflight VR
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. WorldViz
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. TheraSim Inc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. MindMaze
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 2. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR HARDWARE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR SOFTWARE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. GLOBAL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 6. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR AUGMENTED REALITY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR VIRTUAL REALITY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. GLOBAL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 9. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR RESEARCH INSTITUTIONS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 18. U.S. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 19. U.S. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 20. U.S. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 21. CANADA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 22. CANADA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 23. CANADA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 25. MEXICO VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 26. MEXICO VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 30. EUROPE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 31. GERMANY VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 32. GERMANY VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 33. GERMANY VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 34. FRANCE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 35. FRANCE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 36. FRANCE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. UK VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 38. UK VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 39. UK VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 40. ITALY VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 41. ITALY VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 42. ITALY VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 43. SPAIN VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 44. SPAIN VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 45. SPAIN VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 47. REST OF EUROPE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 48. REST OF EUROPE VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 52. ASIA-PACIFIC VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 53. JAPAN VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 54. JAPAN VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 55. JAPAN VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 56. CHINA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 57. CHINA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 58. CHINA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. AUSTRALIA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 60. AUSTRALIA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 61. AUSTRALIA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 62. INDIA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 63. INDIA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 64. INDIA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 65. SOUTH KOREA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 66. SOUTH KOREA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 67. SOUTH KOREA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 69. REST OF ASIA-PACIFIC VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 70. REST OF ASIA-PACIFIC VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 74. LAMEA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 76. BRAZIL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 77. BRAZIL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 78. SAUDI ARABIA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 79. SAUDI ARABIA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 80. SAUDI ARABIA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 81. SOUTH AFRICA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 82. SOUTH AFRICA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 83. SOUTH AFRICA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 85. REST OF LAMEA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 86. REST OF LAMEA VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 87. CAE: KEY EXECUTIVES
TABLE 88. CAE: COMPANY SNAPSHOT
TABLE 89. CAE: OPERATING SEGMENTS
TABLE 90. CAE: PRODUCT PORTFOLIO
TABLE 91. CAE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92. GE HEALTHCARE: KEY EXECUTIVES
TABLE 93. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 94. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 95. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 96. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 98. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 99. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 100. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 101. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102. INTUITIVE SURGICAL, INC.: KEY EXECUTIVES
TABLE 103. INTUITIVE SURGICAL, INC.: COMPANY SNAPSHOT
TABLE 104. INTUITIVE SURGICAL, INC.: OPERATING SEGMENTS
TABLE 105. INTUITIVE SURGICAL, INC.: PRODUCT PORTFOLIO
TABLE 106. INTUITIVE SURGICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. SIEMENS LTD: KEY EXECUTIVES
TABLE 108. SIEMENS LTD: COMPANY SNAPSHOT
TABLE 109. SIEMENS LTD: OPERATING SEGMENTS
TABLE 110. SIEMENS LTD: PRODUCT PORTFOLIO
TABLE 111. SIEMENS LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112. EON REALITY, INC: KEY EXECUTIVES
TABLE 113. EON REALITY, INC: COMPANY SNAPSHOT
TABLE 114. EON REALITY, INC: OPERATING SEGMENTS
TABLE 115. EON REALITY, INC: PRODUCT PORTFOLIO
TABLE 116. EON REALITY, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. BIOFLIGHT VR: KEY EXECUTIVES
TABLE 118. BIOFLIGHT VR: COMPANY SNAPSHOT
TABLE 119. BIOFLIGHT VR: OPERATING SEGMENTS
TABLE 120. BIOFLIGHT VR: PRODUCT PORTFOLIO
TABLE 121. BIOFLIGHT VR: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 122. WORLDVIZ: KEY EXECUTIVES
TABLE 123. WORLDVIZ: COMPANY SNAPSHOT
TABLE 124. WORLDVIZ: OPERATING SEGMENTS
TABLE 125. WORLDVIZ: PRODUCT PORTFOLIO
TABLE 126. WORLDVIZ: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127. THERASIM INC: KEY EXECUTIVES
TABLE 128. THERASIM INC: COMPANY SNAPSHOT
TABLE 129. THERASIM INC: OPERATING SEGMENTS
TABLE 130. THERASIM INC: PRODUCT PORTFOLIO
TABLE 131. THERASIM INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132. MINDMAZE: KEY EXECUTIVES
TABLE 133. MINDMAZE: COMPANY SNAPSHOT
TABLE 134. MINDMAZE: OPERATING SEGMENTS
TABLE 135. MINDMAZE: PRODUCT PORTFOLIO
TABLE 136. MINDMAZE: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALVIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET
FIGURE 10. GLOBAL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET SEGMENTATION, BY COMPONENT
FIGURE 11. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR HARDWARE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR SOFTWARE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR SERVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. GLOBAL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET SEGMENTATION, BY TECHNOLOGY
FIGURE 15. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR AUGMENTED REALITY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR VIRTUAL REALITY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. GLOBAL VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET SEGMENTATION, BY END USER
FIGURE 18. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR RESEARCH INSTITUTIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET FOR CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 26. COMPETITIVE DASHBOARD
FIGURE 27. COMPETITIVE HEATMAP: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET
FIGURE 28. TOP PLAYER POSITIONING, 2023
FIGURE 29. CAE: NET SALES, 2021-2023 ($BILLION)
FIGURE 30. CAE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 31. CAE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 32. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. KONINKLIJKE PHILIPS N.V.: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. INTUITIVE SURGICAL, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. INTUITIVE SURGICAL, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. INTUITIVE SURGICAL, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. SIEMENS LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. SIEMENS LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. SIEMENS LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. EON REALITY, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. EON REALITY, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. EON REALITY, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. BIOFLIGHT VR: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. BIOFLIGHT VR: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. BIOFLIGHT VR: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. WORLDVIZ: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. WORLDVIZ: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. WORLDVIZ: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. THERASIM INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. THERASIM INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. THERASIM INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 56. MINDMAZE: NET SALES, 2021-2023 ($BILLION)
FIGURE 57. MINDMAZE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 58. MINDMAZE: REVENUE SHARE, BY REGION, 2023 (%)

Companies Mentioned

  • CAE
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Intuitive Surgical, Inc.
  • Siemens Ltd
  • Eon Reality, Inc
  • Bioflight VR
  • WorldViz
  • TheraSim Inc
  • MindMaze

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information